Amgen Buy Hold or Sell Recommendation

AMGN -- USA Stock  

USD 205.10  1.90  0.94%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Amgen is 'Hold'. Macroaxis provides Amgen buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Amgen positions. The advice algorithm takes into account all of Amgen available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Amgen buy-and-hold prospective. Check also Amgen Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell AmgenBuy Amgen
Hold

Volatility

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

For the selected time horizon Amgen has a risk adjusted performance of 0.0944, jensen alpha of 0.1693, total risk alpha of 0.18, sortino ratio of 0.0194 and treynor ratio of 1.72
Macroaxis provides buy, hold, or sell suggestion on Amgen to complement and cross-verify current analyst consensus on Amgen. Our buy, hold, or sell recommendation engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure Amgen is not overpriced, please confirm all Amgen fundamentals including its EBITDA, Cash Flow from Operations and the relationship between Price to Book and Total Debt . Given that Amgen has Price to Earning of 60.16 times, we suggest you validate Amgen market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Amgen Thematic Classifications

Robots And Drones IdeaRobots And Drones
Cross-sector firms and funds that develop or invest in technology that can replicate repetitive human actions
Macroaxis Index IdeaMacroaxis Index
Macroaxis power theme of selected equities with solid fundamentals
Baby Boomer Prospects IdeaBaby Boomer Prospects
Mega stocks, funds and ETFs that tend to appeal to people considering retirement from the work force

Amgen Returns Distribution Density

Mean Return0.20Value At Risk1.27
Potential Upside1.72Standard Deviation1.01
 Return Density 
      Distribution 

Institutional Investors

Security TypeSharesValue
Fmr LlcCommon Shares70.7 M13.1 B
Vanguard Group IncCommon Shares49.3 M9.1 B
Capital Research Global InvestorsCommon Shares45.9 M8.5 B
Blackrock IncCommon Shares45.8 M8.5 B
State Street CorpCommon Shares26.5 M4.9 B
Primecap Management CoCommon Shares21.2 M3.9 B
Bank Of America CorpCommon Shares9.2 M1.7 B

Amgen Greeks

α
Alpha over DOW
=0.17
β
Beta against DOW=0.11
σ
Overall volatility
=1.01
Ir
Information ratio =0.0211

Amgen Volatility Alert

Amgen has relatively low volatility with skewness of 0.96 and kurtosis of 2.65. However, we advise all investors to independently investigate Amgen to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.
    
 Better Than Average     
    
 Worse Than Average Compare Amgen to competition

Amgen Fundamental Vs Peers

FundamentalsAmgenPeer Average
Return On Equity10.14 % (15.17) %
Return On Asset9.03 % (15.64) %
Profit Margin10.19 % (5.50) %
Operating Margin53.95 % (10.91) %
Current Valuation134.93 B152.14 B
Shares Outstanding647.27 M1.43 B
Shares Owned by Insiders0.19 % 6.91 %
Shares Owned by Institutions80.84 % 18.37 %
Number of Shares Shorted11.32 M3.24 M
Price to Earning60.16 times40.69 times
Price to Book8.74 times14.44 times
Price to Sales5.61 times17.81 times
Revenue23.19 B9.85 B
Gross Profit18.93 B21.75 B
EBITDA12.51 B1.41 B
Net Income2.36 B517.71 M
Cash and Equivalents29.39 B3.89 B
Cash per Share45.41 times5.17 times
Total Debt34.5 B7.36 B
Debt to Equity231.30 % 0.72 %
Current Ratio3.39 times3.30 times
Book Value Per Share22.97 times13.64 times
Cash Flow from Operations8.55 B1.25 B
Short Ratio5.28 times2.09 times
Earnings Per Share3.34 times2.30 times
Price to Earnings To Growth2.62 times1.22 times
Number of Employees20.8 K10.67 K
Beta1.610.34
Market Capitalization129.98 B29.78 B
Total Asset71.58 B126.86 B
Retained Earnings(438 M)38.24 B
Working Capital29.85 B3.58 B
Current Asset38.52 B36.8 B
   Sale by Omenn Gilbert S of 2000 shares of Amgen [view details]

Amgen Alerts

Trading Alerts and Improvement Suggestions

Amgen has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Over 81.0% of the company shares are held by institutions such as insurance companies
On August 16, 2018 Amgen paid $ 1.32 per share dividend to its current shareholders
Latest headline from MacroaxisInsider: Exercise or conversion by Sean Harper of 16109 shares of Amgen subject to Rule 16b-3

Latest Analysts View

Amgen Current Analysts Recommendations

Target Median Price205.00
Target Mean Price204.26
Recommendation Mean2.30
Target High Price228.00
Number Of Analyst Opinions19
Target Low Price179.00
Check also Amgen Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool. Please also try ETF Directory module to find actively-traded exchange traded funds (etf) from around the world.
Search macroaxis.com